| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/30/1996 | CA1338008C Transdermal flux enhancing compositions |
| 01/28/1996 | CA2154745A1 Treatment of impotence |
| 01/26/1996 | WO1996001625A1 Multiple unit tableted dosage form containing proton pump inhibitor |
| 01/26/1996 | EP0711175A4 Topical compositions for re-epitheliazation of persistent epithelial defects |
| 01/26/1996 | CA2170995A1 Multiple unit tableted dosage form containing proton pump inhibitor |
| 01/25/1996 | WO1996001874A1 Moisture barrier film coating composition, method, and coated form |
| 01/25/1996 | WO1996001845A1 Growth differentiation factor-11 |
| 01/25/1996 | WO1996001841A1 Cationic lipids for delivery of nucleic acids to cells |
| 01/25/1996 | WO1996001840A1 Cationic lipids for delivery of nucleic acids to cells |
| 01/25/1996 | WO1996001663A1 Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values |
| 01/25/1996 | WO1996001652A1 Aqueous risperidone formulations |
| 01/25/1996 | WO1996001648A1 Attenuation of wound healing processes |
| 01/25/1996 | WO1996001645A1 Use of muramyl peptide compounds |
| 01/25/1996 | WO1996001637A1 New pharmaceutical preparation for pain management |
| 01/25/1996 | WO1996001636A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | WO1996001629A1 Hydromorphone therapy |
| 01/25/1996 | WO1996001628A1 Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension |
| 01/25/1996 | WO1996001626A1 Transdermal drug delivery system |
| 01/25/1996 | WO1996001624A1 Multiple unit pharmaceutical preparation containing proton pump inhibitor |
| 01/25/1996 | WO1996001623A1 Multiple unit tableted dosage form i |
| 01/25/1996 | WO1996001622A1 New oral pharmaceutical formulation containing magnesium salt of omeprazole |
| 01/25/1996 | WO1996001621A1 New beads for controlled release and a pharmaceutical preparation containing the same |
| 01/25/1996 | WO1996001620A1 Method of priming an immune response in a one-day old animal |
| 01/25/1996 | WO1996001619A1 Pellet for administration to ruminants |
| 01/25/1996 | WO1996001612A1 A novel drug delivery system |
| 01/25/1996 | WO1996001611A1 Implanted device containing tumor cells for the treatment of cancer |
| 01/25/1996 | WO1996001593A1 Method for delivering a gas-supersaturated fluid to a gas-depleted site and use thereof |
| 01/25/1996 | WO1996001570A1 Cold water-dispersible compositions of fat-soluble active substances |
| 01/25/1996 | WO1996001558A1 Anandamide analogue compositions and method of treating intraocular hypertention using same |
| 01/25/1996 | DE4425322A1 Virostatics in a hydrophobic base for topical use |
| 01/25/1996 | CA2194961A1 Method for delivering a gas-supersaturated fluid to a gas-depleted site and use thereof |
| 01/25/1996 | CA2194890A1 A novel drug delivery system |
| 01/25/1996 | CA2194796A1 Cold water-dispersible compositions of fat-soluble active substances |
| 01/25/1996 | CA2194678A1 Use of muramyl peptide compounds |
| 01/25/1996 | CA2194374A1 Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension |
| 01/25/1996 | CA2194366A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | CA2193992A1 New pharmaceutical preparation for pain management |
| 01/25/1996 | CA2193681A1 New oral pharmaceutical formulation containing magnesium salt of omeprazole |
| 01/25/1996 | CA2188451A1 Hydromorphone therapy |
| 01/25/1996 | CA2170526A1 New beads for controlled release and a pharmaceutical preparation containing the same |
| 01/24/1996 | EP0693481A1 Prodrugs of 5,5-diphenylhydantoin as antiepileptic and antiarrhythmic agents |
| 01/24/1996 | EP0693471A1 Benzylidene-norcamphor derivatives |
| 01/24/1996 | EP0693292A1 Sterile gel compositions for wound treatment |
| 01/24/1996 | EP0693282A2 Duloxetine enteric pellets |
| 01/24/1996 | EP0693281A2 Fluoxetine Pharmaceutical formulations |
| 01/24/1996 | EP0693280A2 Apparatus and process for strengthening low density compression dosage units and products therefrom |
| 01/24/1996 | EP0693277A1 Method for obstructing lacrimal canaliculi with infusible solution or dispersion |
| 01/24/1996 | EP0692972A1 Method for delivering beneficial compositions to hair follicles |
| 01/24/1996 | EP0692961A1 Method of producing liposomes |
| 01/24/1996 | EP0692960A1 Lure for facilitating the administration of drugs to certain animals, particularly dogs |
| 01/24/1996 | EP0692957A1 Multiple w/o/w emulsion preparation process |
| 01/24/1996 | EP0692956A1 Capsule cap |
| 01/24/1996 | EP0578702B1 An agent for animal skin treatment |
| 01/24/1996 | EP0319557B1 Reconstituted hdl particles and uses thereof |
| 01/24/1996 | CN2217981Y Multiple layer health-care buccal tablets for cigarette |
| 01/24/1996 | CN1115252A Ionic molecular conjugates of biodergaable polyesters and bioactive polypeptides |
| 01/24/1996 | CN1115245A Anti-cold inhalation and its prepn. method |
| 01/24/1996 | CN1115240A Pill for stimulating circulation of blood and causing muscles and joints to relax |
| 01/24/1996 | CN1115234A Magnetic inorganic medicine |
| 01/24/1996 | CN1115212A Method for prodn. of chewing gum and bubble gum for prevention and treatment of decayed tooth and periodontitis |
| 01/23/1996 | US5486537 Cinnamic aldehyde, griseofluvin, alcohol |
| 01/23/1996 | US5486508 Cyclodextrin composition |
| 01/23/1996 | US5486507 Porous particle aggregate and method therefor |
| 01/23/1996 | US5486364 Readily available konjac glucomannan as a sustained release excipient |
| 01/23/1996 | US5486362 Controlled, sustained release delivery system for treating drug dependency |
| 01/23/1996 | US5485827 Providing nitrogen oxide for breathing |
| 01/23/1996 | CA1337970C Antibacterial adhesive composition |
| 01/23/1996 | CA1337969C Stable emulsions of highly fluorinated organic compounds |
| 01/20/1996 | CA2154201A1 Use of magnesium hydroxide as a stool softener |
| 01/19/1996 | CA2154996A1 Apparatus and process for strengthening low density compression dosage units and products therefrom |
| 01/19/1996 | CA2153947A1 Sterile gel compositions for wound treatment |
| 01/18/1996 | WO1996001134A1 Osmotic system for delivering of fluid-sensitive somatotropin to bovine animals |
| 01/18/1996 | WO1996001128A2 Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets |
| 01/18/1996 | WO1996001118A1 Biochemically balanced peritoneal dialysis solutions |
| 01/18/1996 | WO1996001112A1 Carbamazepine medicament with retarded active substance release |
| 01/18/1996 | WO1996001109A1 Clavulanate pharmaceutical formulations |
| 01/18/1996 | WO1996001105A1 A method for treating capsules used for drug storage |
| 01/18/1996 | WO1996001104A1 Method and device for implantation of large diameter objects in bovines |
| 01/18/1996 | WO1996001103A1 Multiple encapsulation of oleophilic substances |
| 01/18/1996 | WO1996001102A1 Factor to grow tissue ex vivo |
| 01/18/1996 | WO1996001100A2 Hydrogel for the application of therapeutic and/or cosmetic active substances to the skin |
| 01/18/1996 | WO1996001092A1 Device for the release of an active agent |
| 01/18/1996 | WO1996001057A1 Flash flow formed solloid delivery systems |
| 01/18/1996 | DE4425255A1 Formulierung zur inhalativen Applikation Formulation for inhalation |
| 01/18/1996 | DE4424676A1 Effervescent aluminium contg. antacid compsns. |
| 01/18/1996 | DE4424085A1 Kaltwasserdispergierbare Zubereitungen fettlöslicher Wirkstoffe Kaltwasserdispergierbare preparations of fat-soluble substances |
| 01/18/1996 | CA2194442A1 Hydrogel for the application of therapeutic and/or cosmetic active substances to the skin |
| 01/18/1996 | CA2194371A1 Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets |
| 01/18/1996 | CA2194216A1 Carbamazepine medicament with retarded active substance release |
| 01/18/1996 | CA2194173A1 Method and device for implantation of large diameter objects in bovines |
| 01/18/1996 | CA2194057A1 Factor to grow tissue ex vivo |
| 01/18/1996 | CA2191709A1 A method for treating capsules used for drug storage |
| 01/18/1996 | CA2189870A1 Device for the release of an active agent |
| 01/17/1996 | EP0692510A1 Preparation of anhydride copolymers |
| 01/17/1996 | EP0692249A1 Compounds bearing one or more oxime functions, stabilized in aqueous solution, process to prepare them, and their use as drugs |
| 01/17/1996 | EP0692029A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 01/17/1996 | EP0691992A1 Random block copolymers |
| 01/17/1996 | EP0691886A1 Microcapsules with walls made of cross-linked plant polyphenols, and compositions containing same |
| 01/17/1996 | EP0691885A1 Method of encapsulating substances in biocapsules |
| 01/17/1996 | EP0691850A1 Factor xiii for treatment of skin wounds |